It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BLFS’s FA Score shows that 1 FA rating(s) are green whileCLPT’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BLFS’s TA Score shows that 2 TA indicator(s) are bullish while CLPT’s TA Score has 5 bullish TA indicator(s).
BLFS (@Pharmaceuticals: Other) experienced а -0.79% price change this week, while CLPT (@Medical/Nursing Services) price change was +8.20% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.65%. For the same industry, the average monthly price growth was -2.56%, and the average quarterly price growth was +2.10%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.46%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.22%.
BLFS is expected to report earnings on Nov 06, 2025.
CLPT is expected to report earnings on Aug 12, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.46% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
BLFS | CLPT | BLFS / CLPT | |
Capitalization | 1.09B | 306M | 355% |
EBITDA | 2.72M | -19.93M | -14% |
Gain YTD | -20.493 | -29.649 | 69% |
P/E Ratio | N/A | N/A | - |
Revenue | 87.8M | 32.2M | 273% |
Total Cash | 88.6M | 12.4M | 715% |
Total Debt | 26.9M | 3.44M | 782% |
BLFS | CLPT | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 96 | 74 | |
SMR RATING 1..100 | 92 | 98 | |
PRICE GROWTH RATING 1..100 | 80 | 64 | |
P/E GROWTH RATING 1..100 | 14 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 17 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLPT's Valuation (50) in the null industry is somewhat better than the same rating for BLFS (99) in the Medical Specialties industry. This means that CLPT’s stock grew somewhat faster than BLFS’s over the last 12 months.
CLPT's Profit vs Risk Rating (74) in the null industry is in the same range as BLFS (96) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to BLFS’s over the last 12 months.
BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as CLPT (98) in the null industry. This means that BLFS’s stock grew similarly to CLPT’s over the last 12 months.
CLPT's Price Growth Rating (64) in the null industry is in the same range as BLFS (80) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to BLFS’s over the last 12 months.
BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for CLPT (100) in the null industry. This means that BLFS’s stock grew significantly faster than CLPT’s over the last 12 months.
BLFS | CLPT | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago84% |
Stochastic ODDS (%) | 4 days ago80% | 4 days ago78% |
Momentum ODDS (%) | 4 days ago88% | 4 days ago85% |
MACD ODDS (%) | 4 days ago90% | 4 days ago77% |
TrendWeek ODDS (%) | 4 days ago86% | 4 days ago79% |
TrendMonth ODDS (%) | 4 days ago87% | 4 days ago85% |
Advances ODDS (%) | 26 days ago78% | 5 days ago80% |
Declines ODDS (%) | 11 days ago85% | 11 days ago85% |
BollingerBands ODDS (%) | N/A | 4 days ago82% |
Aroon ODDS (%) | 4 days ago82% | 4 days ago85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EIDIX | 18.06 | 0.09 | +0.50% |
Eaton Vance Global Equity Income I | |||
KTCCX | 15.16 | 0.06 | +0.40% |
DWS Science and Technology C | |||
MSCFX | 29.01 | 0.10 | +0.35% |
Mairs & Power Small Cap | |||
VCSAX | 109.79 | 0.32 | +0.29% |
Vanguard Consumer Staples Index Admiral | |||
HROAX | 12.75 | -0.20 | -1.54% |
M3Sixty Income and Opportunity A |
A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.
Ticker / NAME | Correlation To CLPT | 1D Price Change % | ||
---|---|---|---|---|
CLPT | 100% | +0.28% | ||
ICUI - CLPT | 56% Loosely correlated | -13.13% | ||
NVST - CLPT | 48% Loosely correlated | +0.75% | ||
ISRG - CLPT | 46% Loosely correlated | -0.84% | ||
BLFS - CLPT | 46% Loosely correlated | N/A | ||
A - CLPT | 44% Loosely correlated | +0.56% | ||
More |